Dr. Melania B. Domingo, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 510 Maple Dr, Vidalia, GA 30474 Phone: 912-537-9334 Fax: 912-537-0019 |
News Archive
"As explained in the ruling yesterday, the District Court's determination is only a preliminary step in the legal process that does not affect how the U.S. Patent and Trademark Office (PTO) evaluates patent applications relating to DNA-based inventions."
AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that it has initiated activities intended to complete the clinical development of the growth hormone secretagogue (GHS) / ghrelin agonist compound macimorelin (AEZS-130) which could be the first oral diagnostic test approved for growth hormone deficiency (GHD). Macimorelin is the International Non-proprietary Name (INN) designated for the compound by the World Health Organization (WHO).
Today we celebrate the 10th annual World Sleep Day. It is organized by the World Sleep Society, founded by the World Association of Sleep Medicine (WASM) and the World Sleep Federation (WSF), an international association whose mission is to advance sleep health worldwide.
"Half of the 340,000 deaths of women from pregnancy-related causes each year occur in Africa, almost all in anonymity," the New York Times writes in an article profiling several cases of women who have died during childbirth in Ugandan hospitals.
New research represents a promising step towards better understanding of a key cancer gene. A long-running collaboration between researchers at the Babraham Institute, Cambridge, and the AstraZeneca IMED Biotech Unit reveals new insights into how the PTEN gene may control cell growth and behavior and how its loss contributes to the development and advancement of certain cancers.
› Verified 6 days ago